Molecular cancer genetics in eastern and central Europe.
Olah
E
E
National Institute of Oncology, Budapest, Hungary.
D000328:Adult; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D018567:Breast Neoplasms, Male / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D004252:DNA Mutational Analysis; D005061:Europe, Eastern / Q000453:epidemiology; D005260:Female; D019398:Genes, BRCA1; D005817:Genetic Counseling / Q000458:organization & administration*; D020022:Genetic Predisposition to Disease; D005826:Genetics, Medical / Q000458:organization & administration*; D006801:Humans; D007844:Latvia / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics; D009369:Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000517:prevention & control; D009386:Neoplastic Syndromes, Hereditary / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D009857:Oncogenes; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D014157:Transcription Factors / Q000235:genetics; D014421:Turkey / Q000453:epidemiology
D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors